SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 12,520 shares at $6.45 ($81K) on 2016-05-20, disclosed to the SEC on 2016-05-23.
Open-market sale of $81k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.46 | 1,252 | $8K | 10.0% |
| 2 | $6.46 | 1,252 | $8K | 10.0% |
| 3 | $6.45 | 5,008 | $32K | 40.0% |
| 4 | $6.45 | 5,008 | $32K | 40.0% |
| Total | $6.45 avg | 12,520 | $81K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $14K | — | Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |